Article citationsMore>>
T. Cufer, E. Vrdoljak, R. Gaafar, et al., “Phase II, Open-Label, Randomized Study (SIGN) of Single-Agent Gefitinib (IRESSA) or Docetaxel as Second-Line Therapy in Patients with Advanced (Stage IIIb or IV) Non-Small-Cell Lung Cancer,” Anticancer Drugs, Vol. 17, No. 4, 2006, pp. 401-409.
doi:10.1097/01.cad.0000203381.99490.ab
has been cited by the following article:
Related Articles:
-
Ghada Ezzat Eladawei, Rasha Mohamed Abdellatif, Sheref Mohamed El-Taher
-
Guillermo López Vivanco, Eider Azkona, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Juan Manuel Mañé, Begoña Calvo, Unai Aresti, Aitziber Buque, Inés Marrodán, Alberto Muñoz
-
Eduardo Santiesteban, Leslie Perez, Sailyn Alfonso, Elia Neninger, Soraida Acosta, Yoana Flores, Maurenis Hernandez, Carmen Viada, Robin García, Meylán Cepeda, Daymys Estevez, Yoisbel Moreno, Amparo Macías
-
Milan Rancic, Lidija Ristic, Marina Cekic, Tatjana Pejcic
-
Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama